The transaction is expected to close in the third quarter this year. As a combined company, it will have a total addressable market of approximately $70 billion and include more than 4,600 physician relationships in 38 states.
“With the addition of Sheridan, we will be significantly diversified and differentiated — holding leadership positions in outsourced physician services for anesthesia, children’s services, emergency medicine services and radiology while retaining our standing as a leading owner of freestanding ambulatory surgery centers,” said Christopher Holden, president and CEO of AmSurg, in a news release.
Sheridan is currently owned by private equity firm Hellman & Friedman. The company will be a “significant shareholder” of the combined company post-transaction, according to the release.
In April, Sheridan had announced it hired Credit Suisse Group, Barclays and Goldman Sachs to lead an initial public offering. It has been a private company since 1999.
More Articles on Sheridan Healthcare:
AmSurg to Buy Sheridan Healthcare: 5 Things to Know
3 Steps to do the Impossible With Physician-Led Teams
10 Things to Know About Sheridan Healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.